Home Cart Sign in  
Chemical Structure| 128-57-4 Chemical Structure| 128-57-4

Structure of Sennoside B
CAS No.: 128-57-4

Chemical Structure| 128-57-4

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Sennoside B inhibits PDGF-stimulated cell proliferation, it's a kind of irritant laxative isolated from rhei rhizome and leaves of Cassia angustifolia..

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Sennoside B

CAS No. :128-57-4
Formula : C42H38O20
M.W : 862.74
SMILES Code : O=C1C2=C(O)C=C(C(O)=O)C=C2[C@@H](C3=C1C(O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)=CC=C3)[C@@H](C5=C6C(O[C@@H]7O[C@H](CO)[C@@H](O)[C@H](O)[C@H]7O)=CC=C5)C8=CC(C(O)=O)=CC(O)=C8C6=O
MDL No. :MFCD00151528
InChI Key :IPQVTOJGNYVQEO-AIFLABODSA-N
Pubchem ID :91440

Safety of Sennoside B

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of Sennoside B

RTK

Isoform Comparison

Biological Activity

Target
  • PDGFR

In Vitro:

Cell Line
Concentration Treated Time Description References
C8166 cells 4.73 μM 72 h To evaluate the inhibitory activity of SA and SB against HIV-1-induced cytopathic effects (CPE). Results showed an IC50 of 4.73 μM for SB. PMC10561090
L929 cells 100 µM 18 h To evaluate the inhibitory effect of Sennoside B on TNF-α-induced L929 cell toxicity, results showed 80.3% inhibition at 100 µM concentration PMC8465676
HeLa cells 0.32 µM 18 h To evaluate the inhibitory effect of Sennoside B on TNF-α-induced HeLa cell toxicity, results showed an IC50 value of 0.32 µM PMC8465676
AGS gastric cells 50 μM and 100 μM To evaluate the effect of Sennoside B on PGE2 production, results showed that Sennoside B increased PGE2 concentration in a dose-dependent manner. PMC4556206

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Mice C57BL/6 mice Intraperitoneal injection 9.3 mg/kg Single injection, followed by injection of Ag-treated B cells after 2 hours To evaluate the inhibitory effect of Sennoside B on antigen transfer between B cells and macrophages/dendritic cells in vivo, results showed that Sennoside B significantly reduced antigen transfer, comparable to SR-A-deficient mice. PMC3285311
Sprague-Dawley rats HCl•EtOH-induced gastritis and indomethacin-induced gastric ulcer models Oral 100 mg/kg Single dose, 30 minutes before inducing gastritis or gastric ulcer To evaluate the gastroprotective effects of Sennoside B, results showed that Sennoside B significantly reduced lesion indices, inhibited gastric acid secretion, and increased gastric juice pH. PMC4556206

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.16mL

0.23mL

0.12mL

5.80mL

1.16mL

0.58mL

11.59mL

2.32mL

1.16mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories